BCM
MLNT

BlueCrest Capital Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

BlueCrest Capital Management’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,120
Closed -$42K – 1641
2018
Q3 		$42K Buy
+2,120
New +$42K ﹤0.01% 1433